返回
Hua Medicine (Shanghai) Ltd.（02552.HK）價格
02552.HK 股價走勢圖
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
休市： Jan 16, 16:00:00 HKT
暫無資料Earnings FAQ
02552.HK 最近的每股盈餘與預期相比如何？
Hua Medicine (Shanghai) Ltd. 02552.HK 上一季度的收入表現如何？
Hua Medicine (Shanghai) Ltd. 的收入預期是多少？
Hua Medicine (Shanghai) Ltd. 的盈利品質評分是多少？
Hua Medicine (Shanghai) Ltd. 何時發布財報？
Hua Medicine (Shanghai) Ltd. 的預期收益是多少？
Hua Medicine (Shanghai) Ltd. 是否超出收益預期？
關鍵數據
前收市價
$3.41
開盤價
$3.41
當日範圍
$3.2 - $3.41
52週區間
$1.24 - $4.95
交易量
5.3M
平均成交量
3.5M
每股盈餘 (TTM)
1.21
股息收益率
--
市值
$3.2B
什麼是 HUA MEDICINE-B？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.